Literature DB >> 10221315

Cannabis use and cognitive decline in persons under 65 years of age.

C G Lyketsos1, E Garrett, K Y Liang, J C Anthony.   

Abstract

The purpose of this study was to investigate possible adverse effects of cannabis use on cognitive decline after 12 years in persons under age 65 years. This was a follow-up study of a probability sample of the adult household residents of East Baltimore. The analyses included 1,318 participants in the Baltimore, Maryland, portion of the Epidemiologic Catchment Area study who completed the Mini-Mental State Examination (MMSE) during three study waves in 1981, 1982, and 1993-1996. Individual MMSE score differences between waves 2 and 3 were calculated for each study participant. After 12 years, study participants' scores declined a mean of 1.20 points on the MMSE (standard deviation 1.90), with 66% having scores that declined by at least one point. Significant numbers of scores declined by three points or more (15% of participants in the 18-29 age group). There were no significant differences in cognitive decline between heavy users, light users, and nonusers of cannabis. There were also no male-female differences in cognitive decline in relation to cannabis use. The authors conclude that over long time periods, in persons under age 65 years, cognitive decline occurs in all age groups. This decline is closely associated with aging and educational level but does not appear to be associated with cannabis use.

Entities:  

Mesh:

Year:  1999        PMID: 10221315     DOI: 10.1093/oxfordjournals.aje.a009894

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Should physicians support the medical use of marijuana? Yes: it can be effective when all else fails. Point.

Authors:  William S Eidelman
Journal:  West J Med       Date:  2002-03

Review 2.  The Use of Cannabinoids in Treating Dementia.

Authors:  Megan Weier; Wayne Hall
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

3.  Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence.

Authors:  Jiansong Xu; Adrianna Mendrek; Mark S Cohen; John Monterosso; Paul Rodriguez; Sara L Simon; Arthur Brody; Murray Jarvik; Catherine P Domier; Richard Olmstead; Monique Ernst; Edythe D London
Journal:  Biol Psychiatry       Date:  2005-07-15       Impact factor: 13.382

4.  Chronic cognitive impairment in users of 'ecstasy' and cannabis.

Authors:  Anthony Klugman; John Gruzelier
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

5.  Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study.

Authors:  Madeline H Meier; Avshalom Caspi; Andrea Danese; Helen L Fisher; Renate Houts; Louise Arseneault; Terrie E Moffitt
Journal:  Addiction       Date:  2017-09-05       Impact factor: 6.526

6.  Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status.

Authors:  Ole Rogeberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

Review 7.  In the shadow of academic medical centers: a systematic review of urban health research in Baltimore City.

Authors:  Nadra C Tyus; M Christopher Gibbons; Karen A Robinson; Claire Twose; Bernard Guyer
Journal:  J Community Health       Date:  2010-08

Review 8.  Residual neuropsychologic effects of cannabis.

Authors:  H G Pope; A J Gruber; D Yurgelun-Todd
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

Review 9.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 10.  Substance use in older HIV-infected patients.

Authors:  E Jennifer Edelman; Jeanette M Tetrault; David A Fiellin
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.